Citius Pharmaceuticals (CTXR) Stock Chart & Stock Price History $1.82 -0.03 (-1.35%) As of 01:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Citius Pharmaceuticals Stock Price Performance 5 Day Performance-32.16%1 Month Performance-43.85%3 Month Performance-55.78%6 Month Performance-87.78%Year-To-Date Performance-54.38%1 Year Performance-90.52% Receive CTXR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CTXR Stock Chart for Friday, February, 21, 2025 CTXR Chart by TradingView Citius Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/20/2025$2.15$1.85-13.95%$2.19$1.47453,200 shs$15.90 million02/19/2025$2.48$2.15-13.13%$2.97$2.011.56 million shs$18.47 million02/18/2025$2.69$2.48-7.99%$2.66$2.42152,421 shs$21.26 million02/17/2025$2.69$2.69$2.82$2.6498,489 shs$23.11 million02/14/2025$2.70$2.69-0.37%$2.82$2.6498,489 shs$23.11 million02/13/2025$2.62$2.70+3.05%$2.85$2.58104,569 shs$23.19 million02/12/2025$2.63$2.62-0.38%$2.68$2.5540,706 shs$22.51 million02/11/2025$2.70$2.63-2.59%$2.73$2.5550,898 shs$22.59 million02/10/2025$2.67$2.70+1.12%$2.84$2.5894,647 shs$23.19 million02/07/2025$2.65$2.67+0.75%$2.75$2.5854,010 shs$22.94 million Get the Latest News and Ratings for CTXR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/06/2025$2.65$2.65$2.69$2.51101,630 shs$22.76 million02/05/2025$2.59$2.65+2.32%$2.65$2.5056,694 shs$22.76 million02/04/2025$2.69$2.59-3.72%$2.70$2.5174,652 shs$22.25 million02/03/2025$2.69$2.69$2.74$2.6050,799 shs$23.12 million01/31/2025$2.83$2.69-4.95%$2.83$2.6587,868 shs$23.11 million01/30/2025$2.79$2.83+1.43%$2.90$2.60101,027 shs$24.31 million01/29/2025$2.91$2.79-4.12%$3.05$2.70117,893 shs$23.97 million01/28/2025$3.02$2.91-3.64%$3.13$2.80109,720 shs$25.00 million01/27/2025$3.30$3.02-8.48%$3.35$3.0288,692 shs$25.94 million01/24/2025$3.15$3.30+4.76%$3.40$3.02165,064 shs$28.35 million01/23/2025$3.15$3.15$3.18$3.0050,833 shs$27.06 million01/22/2025$3.25$3.15-3.08%$3.26$3.1174,805 shs$27.06 million01/21/2025$3.30$3.25-1.52%$3.29$3.1461,359 shs$27.92 million01/20/2025$3.30$3.30$3.31$3.1378,395 shs$25.51 million Related Companies JSPR Stock Chart ANRO Stock Chart SKYE Stock Chart DBVT Stock Chart IMUX Stock Chart CTOR Stock Chart GALT Stock Chart INZY Stock Chart ABOS Stock Chart ENTX Stock Chart Receive CTXR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTXR) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
